E 20 More Psychedelic Stocks


image source

Eleven stocks in the munKNEE Pure-Play Psychedelic Stock Index went up 11.3% last week. Our index includes stocks trade between US $0.10 and US$1, and have market caps between $10 and $75 million. That being said, there are another 20 psychedelic stocks are not eligible for inclusion in the Index (i.e. even smaller). This article identifies, describes and tracks the performance of those "shroom" stocks divided into 4 segments for the sake of comparison. TM Editors Note: Keep in mind that using percentages for comparison is virtually meaningless when prices are this low.

Segment One

The following 10 psychedelic stocks are not included in the munKNEE Pure-Play Psychedelic Stock Index because their market caps are less than US$10M and/or they also trade for less than US$0.10/share. They are noteworthy nevertheless.

  1. New Wave Holdings Inc. (TRMNF) +150.0% to US$0.05/share
    • New Wave will focus on supporting research on active psychedelic compounds, creation of consumer products based on functional mushrooms, and developing an IP portfolio focusing on psilocybin, LSD, MDMA, and ketamine derived treatments for neuropsychiatric diseases.
    • For more information on the company visit its website here.
  2. Codebase Ventures Inc. (BKLLF) +71.4% to US$0.12/share
    • Codebase Ventures, an investment firm offering investors a diverse portfolio of opportunities, has a direct stake in Red Light Holland (see below), a publicly-traded entity involved in the psychedelic market through its subsidiary Titan Shrooms & Psychedelics.
    • For more information on the company visit its website here.
  3. Red Light Holland Corp. (TRUFF) +66.7% to US$0.10/share
    • Produces and distributes legally sanctioned recreational psilocybin truffles in the Netherlands and has financial backing from investment firm Codebase Ventures (see above).
    • For more information on the company visit its website here.
  4. Graph Blockchain Inc. (REGRF) + 50.0% to US$0.02/share
    • Acquired Shroom Street in a deal worth C$1 million and plans to pair its technology with an upcoming e-commerce platform for its psychedelic business purchase, set to launch at the end of 2020 for online sales in legal jurisdictions.
    • For more information on the company visit its website here.
  5. Cybin Inc. (CLXPF) +25.7% to $0.93
    • Cybin Corp. is focused on psychedelic drug development, unique delivery mechanisms, improved novel compounds, and protocols that target psychiatric and neurological conditions.
    • For more information on the company visit its website here.
  6. Lobe Sciences Ltd. (LOBE) +25.0% to US$0.05/share
    • Acquired Eleusian Biosciences Corp. in July to enable it to focus on developing proprietary technologies involving psilocybin, NAC, and MDMA for mTBI, PTSD, and brain injuries
      • For more information on the company visit its website here.
  7. Better Plant Inc. (VEGGF) +/-0 %
    • Better Plant, formerly Yield Growth, develops, manufactures, markets, sells, and distributes plant-based products.
    • Its subsidiary, NeonMind Biosciences Inc., is launching a line of coffees infused with health optimizing medicinal functional (edible) mushrooms including reishi, cordyceps, lion's mane, and turkey tail mushrooms.
    • NeonMind is also engaged in research into developing a psilocybin (psychedelic) mushroom-based product for weight loss and has applied for a Section 56 Exemption to begin preclinical trials to study its pending psychedelic medicine patents.
    • intends to undertake clinical trials on the therapeutic effects of psilocybin and eventually launch branded products to support immune, cognitive, memory, and other brain functions.
    •  For more information on the company visit its website here.
  8. EHave Inc. (EHVVF) +/-0%
    • Its focus is on delivering evidence-based interventions to patients to prevent or treat brain disorders or diseases through the use of digital therapeutics, psychedelics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes.
    • For more information on the company visit its website here.
  9. Minerco Corp. (MINE) +/-0%
    • Acquired by psilocybin research and investment firm Mushrooms International Enterprises and is focused on finding the most effective strategies in producing and extracting the psilocybin from within psilocybin mushrooms.
    • Relocated its corporate offices to Jamaica as the country does not have any laws labeling magic mushrooms as illicit drugs and is in close proximity to the world's first magic mushroom research center, located at the University of the West Indies in Mona, Jamaica.
    • For more information on the company visit its website here.
  10. Thoughtful Brands Inc. (PEMTF) +/-0%
    • Developed an e-commerce platform for hemp-derived cannabidiol (CBD) products in the U.S. and Europe and now plans to expand its operations in Europe to explore the potential of psychedelic treatments.
    • Brought in privately held Verrian, which owns a manufacturing facility in Germany, with the intention of making it the psychedelic research hub for psilocybin mushroom therapies against opioid addiction.
    • For more information on the company visit its website here.
1 2 3
View single page >> |

Disclosure:This article discusses one or more penny stocks and/or microcaps. Such stocks are easily manipulated; do your own careful due diligence.

Visit   more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.